Electroporation Buffer with Serum Albumin for Cell Viability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current electroporation methods suffer from low transfection efficiency and high cytotoxicity, leading to poor cell viability across various cell lines, with existing buffers failing to balance electrical stress and material transfer effectively.
Innovation Solution
Development of electroporation buffers with approximately physiological ionic strength and pH, supplemented with serum or purified proteins, such as serum albumin, to stabilize cells and enhance DNA transfer efficiency while minimizing cell death.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If electroporation is applied to achieve high transfection efficiency, then DNA transfer into cells is improved, but cell viability deteriorates due to high cytotoxicity and cell lysis
Solution Approach 1:
The patent modifies the chemical composition parameters of the electroporation buffer by incorporating physiological salts (NaCl, KCl, CaCl2, MgCl2) at specific concentrations, buffering agents (HEPES, Tris) at controlled pH levels, and protective additives (sorbitol, mannitol, serum albumin). These parameter changes create an optimized buffer environment that reduces electrical stress on cells during electroporation, thereby maintaining cell viability while preserving transfection efficiency
Solution Approach 2:
The patent introduces a specially formulated buffer solution as an intermediary medium between the electrical field and the cells. This buffer acts as a mediator that absorbs and dissipates electrical stress, protecting cells from direct damage while still allowing DNA transfer. The buffer contains protective agents like serum albumin and sugar alcohols that intermediate the harmful effects of electroporation
2Adaptability or versatility
If basic media or serum-supplemented media is used as electroporation buffer, then cell compatibility is improved, but transfection efficiency deteriorates due to poor buffer quality
Solution Approach 1:
The patent creates a composite electroporation buffer by combining multiple components: physiological salts for ionic balance, buffering agents for pH control, sugar alcohols (sorbitol, mannitol) for osmotic protection, and serum albumin for cellular protection. This composite formulation integrates the benefits of cell compatibility with enhanced transfection efficiency, overcoming the limitations of using basic media or simple serum supplements alone
3Productivity
If hypoosmolar buffers are used to increase cell volume and pore formation, then transfection efficiency is improved, but cell lysis increases reducing cell viability
Solution Approach 1:
The patent optimizes the osmolarity parameter of the buffer by incorporating sugar alcohols (sorbitol, mannitol) at specific concentrations that provide mild osmotic stress to increase cell volume and membrane permeability for improved DNA uptake, while simultaneously maintaining sufficient ionic strength and protective agents to prevent excessive cell lysis. This balanced parameter adjustment resolves the contradiction between enhancing transfection and preventing cell damage
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed buffers significantly improve cell viability and transfection efficiency across a wide range of cell lines, reducing cell lysis and maintaining cell health during electrical stress, as demonstrated by high transfection rates and low cell loss in various experiments.
Implementation Method 1
electrical stress on the cell due to reduced current flow in the solution
Implementation Method 2
Electroporation involves the application of an electrical current to a mixture of cells so as to cause the opening of the cell membrane and subsequent entry of material into the cell through pores
Data Source
AI summary
The subject invention concerns an electroporation buffer that allows for enhanced transfection efficiency and cell viability of cells during application of an electric current. Buffers of the invention provide for maximum transfer of target particles into cells while maintaining the health and growth potential of the cell population. Compositions of the invention comprise electroporation buffers of approximately physiological ionic strength and pH, and having serum or purified proteins, such as serum albumin, added thereto. The subject invention is suitable for use with any cell type. The subject invention also concerns methods of electroporation using an electroporation buffer of the invention.